Johnson & Johnson seeks to end decade-long talc litigation with $5.5 billion settlement

Johnson & Johnson has struck a substantial deal worth more than five billion dollars, aimed at settling numerous lawsuits that allege cancer linked to its talc products. Following an ineffective bankruptcy resolution attempt, this latest agreement will facilitate quicker claims disbursement while keeping the door open for others who develop cancer-related claims in the future.

Raccontata damorningstar.comhealio.comchannelnewsasia.comaljazeera.comthehindubusinessline.comeconomictimes.indiatimes.comrappler.comrnz.co.nznewsbytesapp.comthehindu.comtheguardian.comabc.net.au+6 altre